Brexafemme (Ibrexafungerp)

Brexafemme comes as an oral tablet that contains ibrexafungerp citrate, a triterpenoid antifungal agent. It is widely used in adults and post-menarchal pediatric females for:

• treatment of vulvovaginal candidiasis (VVC) or Vaginal Yeast Infection.
• reduction in the occurrence of recurrent vulvovaginal candidiasis (RVVC).

Recommended Dosage: Brexafemme tablets may be taken with or without food, exactly as your doctor tells you to take them. Take two tablets (300 mg) orally in the morning, and take two tablets (300) orally in the evening. If possible, the two doses (2 pills each) should be taken approximately 12 hours apart.

Treatment of VVC: The recommended dosage in adult and post-menarchal pediatric females is 300 mg (2 Brexafemme 150 mg tablets) administered around 12 hours apart (in the morning and in the evening) for one day, for a total daily dosage of 600 mg (4 Brexafemme 150 mg tablets).

Reduction in the Incidence of RVVC: The recommended dosage in adult and post-menarchal pediatric females is 300 mg (2 Brexafemme 150 mg tablets) administered around 12 hours apart (in the morning and in the evening) for a single day, for a total daily dosage of 600mg (four 150 mg pills of Brexafemme) monthly for 6 months.

• Brexafemme 150 mg is contraindicated in pregnancy because it may be responsible for causing fetal harm behalf of the data from animal reproductive studies.
• For females of reproductive age, verify that the respective patient is not pregnant before starting Ibrexafungerp 150 mg treatment. Reassessing the pregnancy status before each dose is recommended when this medicine is used monthly for six months for a reduction in the incidence of RVVC.
• Females of reproductive age should use appropriate contraception during the treatment of VVC (vulvovaginal candidiasis) and throughout the six-month treatment time span for a reduction in the incidence of RVVC with Brexafemme tablets and, for four days after the final dose.
• Patients should inform their healthcare specialist if they are on any other medicines as certain medicines can boost or scale down blood concentrations of Ibrexafungerp or Ibrexafungerp may boost or scale down blood concentrations of certain medicines.

What documents are required to import BREXAFEMME to India?

BREXAFEMME (ibrexafungerp) tablets can be imported by patients or government hospitals in the name of the patients only.

The following documentation is required to import the product:

1. A valid prescription from a qualified doctor.
2. Patient’s diagnostic reports
3. Patient’s ID Proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

1. A valid prescription from the Doctor
2. Import permit if applicable

Is BREXAFEMME available in India?

BREXAFEMME (ibrexafungerp tablet) is a prescription drug that legally requires a medical prescription to be dispensed.

Urgent Meds helps import cancer medicines on the named patient supply (NPS). Urgent Meds is the facilitator providing input on:

• Availability of Brexafemme in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• Medicine Price.
• Finding genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

BREXAFEMME can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

Urgent Meds can facilitate the supply of BREXAFEMME (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).

Please contact +1-647-818-4196 or write to us at info@urgentmeds.in for Brexafemme price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Urgent Meds is proficient in sourcing BREXAFEMME (Cancer Treatment Medicines) from around the world and has the capability to supply it. We offer global access to the best available treatment for our customers worldwide.

Urgent Meds is committed to dispensing any valid prescription promptly. All prescriptions are dispensed and verified by registered pharmacists and are dispatched only to the patient’s address from New Delhi, India. Your health and well-being are our top priorities.

What is the Generic Name for the trade name drug Brexafemme®?

Ibrexafungerp is the Generic Name for the trade name drug Brexafemme®.

What is the Manufacturer’s Name of Brexafemme®?

Brexafemme® is manufactured by Scynexis, Inc.

Is Brexafemme® approved by the FDA?

Yes, Brexafemme® is approved by the FDA. Date of first approval: June 1, 2021.

What is the dosage and form of Brexafemme® supplied?

Brexafemme® is supplied as Tablets: 150 mg for oral administration.

What are the most common side effects of Brexafemme®?

The most common side effects of Brexafemme® include nausea, loose stools, vomiting, dizziness, and stomach pain.

How much does Brexafemme® cost in India?

The medicine Brexafemme cost in India can vary. To buy this triterpenoid antifungal agent authentically, one can call or WhatsApp +1-647-818-4196 or send mail to info@urgentmeds.in.

What are the storage conditions of Brexafemme® Tablets?

Tablets of Brexafemme are packaged in polyvinyl/polyvinylidene chloride child-proof blister packs, four tablets per pack. Store at 20-25°C (68-77°F). Brief exposure to 15-30°C (59-86°F) is permitted.

Is it safe to buy Brexafemme® tablets online from India?

Yes, you can buy Brexafemme tablets online at the best price from Urgent Meds if the medicine has not been approved or is not available in your home country.

For more information, please contact +1-647-818-4196 or email us at info@urgentmeds.in.